Robert Lutz
Company: Iksuda Therapeutics
Job title: Chief Scientific Officer
Seminars:
Chair’s Closing Remarks 4:30 pm
day: Conference Day Two pt 2
Chair’s Opening Remarks 8:20 am
day: Conference Day Two pt 1
Chair’s Closing Remarks 6:30 pm
day: Conference Day One pt 2
Correlating ADC Design Factors to Successful Efficacy & Safety Profiles in the Clinic 5:00 pm
• Accurately characterising antibody, linker, payload, and overall conjugate contributions to ADC clinical performance • Deep diving into ADC case studies to understand differentiated design impact on clinical safety and efficacy profiles • Explaining favourable safety and efficacy profiles attributed to ADC designs against the same target or using different payloadsRead more
day: Conference Day One pt 2